BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34113394)

  • 1. Effect of melanoma stem cells on melanoma metastasis.
    Yin Q; Shi X; Lan S; Jin H; Wu D
    Oncol Lett; 2021 Jul; 22(1):566. PubMed ID: 34113394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells and targeted approaches to melanoma cure.
    Murphy GF; Wilson BJ; Girouard SD; Frank NY; Frank MH
    Mol Aspects Med; 2014 Oct; 39():33-49. PubMed ID: 24145241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma stem cells: not rare, but well done.
    Girouard SD; Murphy GF
    Lab Invest; 2011 May; 91(5):647-64. PubMed ID: 21445060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer stem cells: new insights and perspectives.
    Dorado J; Lonardo E; Miranda-Lorenzo I; Heeschen C
    J Gastroenterol; 2011 Aug; 46(8):966-73. PubMed ID: 21698355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the PI3K-Akt-mTOR signaling pathway involved in vasculogenic mimicry promoted by cancer stem cells.
    Murai T; Matsuda S
    Am J Cancer Res; 2023; 13(11):5039-5046. PubMed ID: 38058805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of Melanoma with Stem Cell Properties.
    Seftor EA; Margaryan NV; Seftor REB; Hendrix MJC
    Adv Exp Med Biol; 2019; 1139():105-114. PubMed ID: 31134497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in Lung Stem Cells and Lung Cancer Stem Cells].
    Yin H; Deng J
    Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):633-9. PubMed ID: 26483336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
    Parte SC; Batra SK; Kakar SS
    J Ovarian Res; 2018 Aug; 11(1):69. PubMed ID: 30121075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal cancer stem cells and implications for future therapeutics.
    Qian X; Tan C; Wang F; Yang B; Ge Y; Guan Z; Cai J
    Onco Targets Ther; 2016; 9():2247-54. PubMed ID: 27143920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133⁺ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: significance for melanoma treatment.
    El-Khattouti A; Sheehan NT; Monico J; Drummond HA; Haikel Y; Brodell RT; Megahed M; Hassan M
    Cancer Lett; 2015 Feb; 357(1):83-104. PubMed ID: 25449786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
    Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
    Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathology underlying the robustness of cancer stem cells.
    Yoshida GJ; Saya H
    Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.